Seeking Alpha Seeking Alpha Portfolio App for iPad  The
biotechnology industry has always appealed to investors looking
for the next home run investment. One niche within that industry
that appears poised to soar deals with small molecule drugs used
to treat diseases. With billions of dollars being poured into
this space each year, the stakes are high but so are the
rewards. One company that appears on the verge of appreciating
significantly is BioCryst Pharmaceuticals (BCRX). Below are
several reasons why investors should consider adding a position
soon.  Company Background  BioCryst Pharmaceuticals designs,
optimizes and develops novel small-molecule drugs that block key
enzymes involved in infectious and inflammatory diseases.
BioCryst uses revolutionary drug design, which incorporates
multiple scientific disciplines including biology,
crystallography, medicinal chemistry and computer...